SPECTRAL MEDICAL INC (EDT.CA) Stock Price, Quote, News and Overview
TSX:EDT - Toronto Stock Exchange - CA8475771033 - Common Stock - Currency: CAD
EDT.CA Quote, Performance and Key Statistics
TSX:EDT (5/15/2025, 7:00:00 PM)
0.84
+0.03 (+3.7%)
The current stock price of EDT.CA is 0.84 CAD. In the past month the price increased by 2.44%. In the past year, price increased by 68%.
EDT.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 239.02M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 189.29M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 168.75M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 83.70M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 15 | 69.92M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 64.22M | ||
| BLU.CA | BLUENERGIES LTD | N/A | 58.33M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 55.21M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 55.07M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 51.43M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 34 | 47.95M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 27.46M |
Related stock screener links
About EDT.CA
Company Profile
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 29 full-time employees. The firm develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. The company has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. The company is continuing its legacy business of manufacturing and selling certain proprietary reagents. The company develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.
Company Info
SPECTRAL MEDICAL INC
135 The West Mall, Unit 2
TORONTO ONTARIO M9C 1C2 CA
CEO: Chris Seto
Employees: 29
Phone: 14166263233
SPECTRAL MEDICAL INC / EDT.CA FAQ
What is the stock price of SPECTRAL MEDICAL INC today?
The current stock price of EDT.CA is 0.84 CAD. The price increased by 3.7% in the last trading session.
What is the ticker symbol for SPECTRAL MEDICAL INC stock?
The exchange symbol of SPECTRAL MEDICAL INC is EDT and it is listed on the Toronto Stock Exchange exchange.
On which exchange is EDT.CA stock listed?
EDT.CA stock is listed on the Toronto Stock Exchange exchange.
What is the price forecast or stock price prediction for SPECTRAL MEDICAL INC stock?
5 analysts have analysed EDT.CA and the average price target is 2.35 CAD. This implies a price increase of 179.29% is expected in the next year compared to the current price of 0.84. Check the SPECTRAL MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SPECTRAL MEDICAL INC worth?
SPECTRAL MEDICAL INC (EDT.CA) has a market capitalization of 239.50M CAD. This makes EDT.CA a Micro Cap stock.
How many employees does SPECTRAL MEDICAL INC have?
SPECTRAL MEDICAL INC (EDT.CA) currently has 29 employees.
What are the support and resistance levels for SPECTRAL MEDICAL INC (EDT.CA) stock?
SPECTRAL MEDICAL INC (EDT.CA) has a support level at 0.84. Check the full technical report for a detailed analysis of EDT.CA support and resistance levels.
Is SPECTRAL MEDICAL INC (EDT.CA) expected to grow?
The Revenue of SPECTRAL MEDICAL INC (EDT.CA) is expected to grow by 23.53% in the next year. Check the estimates tab for more information on the EDT.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SPECTRAL MEDICAL INC (EDT.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EDT.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EDT.CA, evaluating the profitability, health, valuation and growth aspects
- SPECTRAL MEDICAL INC (EDT.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SPECTRAL MEDICAL INC (EDT.CA) Sales and EPS estimates to see what analysts future expectations are.
- SPECTRAL MEDICAL INC (EDT.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SPECTRAL MEDICAL INC (EDT.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- SPECTRAL MEDICAL INC (EDT.CA) Stock Chart to make your own analysis
- SPECTRAL MEDICAL INC (EDT.CA) Latest news and press-releases to stay up to date.
Does SPECTRAL MEDICAL INC (EDT.CA) stock pay dividends?
EDT.CA does not pay a dividend.
When does SPECTRAL MEDICAL INC (EDT.CA) report earnings?
SPECTRAL MEDICAL INC (EDT.CA) will report earnings on 2025-08-07.
What is the Price/Earnings (PE) ratio of SPECTRAL MEDICAL INC (EDT.CA)?
SPECTRAL MEDICAL INC (EDT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).
EDT.CA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to EDT.CA. When comparing the yearly performance of all stocks, EDT.CA is one of the better performing stocks in the market, outperforming 92.4% of all stocks.
EDT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EDT.CA. Both the profitability and financial health of EDT.CA have multiple concerns.
EDT.CA Financial Highlights
Over the last trailing twelve months EDT.CA reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS decreased by -42.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -289.53% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EDT.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to EDT.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of -23.87% and a revenue growth 23.53% for EDT.CA